Literature DB >> 11031692

Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease.

P Brouwers1, L Civitello, C DeCarli, P Wolters, S Sei.   

Abstract

The relationships between viral load in plasma and cerebrospinal fluid (CSF) and computed tomography (CT) brain scan abnormalities were studied in 39 children between 0.5 and 13 years of age with symptomatic HIV-1 disease. Quantitative RNA PCR was used to determine HIV-1 RNA levels and a semiquantitative analog rating technique was used to evaluate non-contrast CT brain scans. CSF HIV-1 RNA copy number correlated significantly with CT brain scan ratings for severity of cortical atrophy (r = 0.36; P < 0.05) but not with ratings of intracerebral calcifications (r = -12; NS). The difference between these two correlations was significant (P < 0.05). Plasma HIV-1 RNA copy number did not correlate significantly with any CT brain scan ratings or with CSF viral load (r = 0.05; NS). Severity of cortical atrophy appeared to reflect the level of viral load in the CSF, supporting the notion that active HIV-1 replication in the CNS is at least in part responsible for such brain abnormalities in children. The lack of correlation of intracerebral calcifications with other CT brain scan abnormalities as well as with CSF viral load suggests that this lesion is relatively independent and may reflect a different neuropathologic process.

Entities:  

Mesh:

Year:  2000        PMID: 11031692     DOI: 10.3109/13550280009018303

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

Review 1.  Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents.

Authors:  Jacqueline Hoare; Gabrielle L Ransford; Nicole Phillips; Taryn Amos; Kirsten Donald; Dan J Stein
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

2.  HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children.

Authors:  Carmen Cantó-Nogués; Silvia Sánchez-Ramón; Susana Alvarez; César Lacruz; Ma Angeles Muñóz-Fernández
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 3.  Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.

Authors:  Lucy Civitello
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 4.  HIV-1, chemokines and neurogenesis.

Authors:  P B Tran; R J Miller
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  Clinical associations of white matter damage in cART-treated HIV-positive children in South Africa.

Authors:  Jacqueline Hoare; Jean-Paul Fouche; Nicole Phillips; John A Joska; Kirsten A Donald; Kevin Thomas; Dan J Stein
Journal:  J Neurovirol       Date:  2015-01-21       Impact factor: 2.643

Review 6.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive).

Authors:  Elyse J Singer; H Aaron Aronow; Shing-Yi Lee; Charles H Hinkin; Tadd Lazarus
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

8.  Early immunological predictors of neurodevelopmental outcomes in HIV-infected children.

Authors:  Jutarat Mekmullica; Pim Brouwers; Manhattan Charurat; Mary Paul; William Shearer; Hermann Mendez; Clemente Diaz; Jennifer S Read; Prosanta Mondal; Renee Smith; Kenneth McIntosh
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

9.  Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.

Authors:  Steven R Randall; Christopher M R Warton; Martha J Holmes; Mark F Cotton; Barbara Laughton; Andre J W van der Kouwe; Ernesta M Meintjes
Journal:  Front Neuroanat       Date:  2017-11-02       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.